Watering eye, also known as epiphora or tearing, is a condition in which there is an overflow of tears onto the face, often without a clear explanation. There is insufficient tear film drainage from the eye(s) – instead of all the tears draining through the nasolacrimal system, they overflow onto the face. Epiphora can develop at any age.
UroToday.com – An article in the online edition of Cancer assesses differences in prostate cancer (CaP) treatment, trust and regular patient care based upon patient race. The North Carolina-Louisiana prostate Cancer Project (PCaP) is a population-based study of men identified shortly after CaP diagnosis.
Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for BYETTA® (exenatide) injection. BYETTA is now approved for use as a stand-alone medication (monotherapy) along with diet and exercise to improve glycemic control in adults with type 2 diabetes.
Mary Harney T.D., Minister for Health and Children met with representatives of Dignity 4 Patients. The Minister briefed them on the decision to establish an independent review to examine whether further investigation into the case of Mr. Michael Shine would be of public benefit.
A statewide effort to improve care for patients with diabetes across Mississippi, particularly for patients considered to be “medically underserved ,” is being announced by the Centers for Medicare & Medicaid Services (CMS). The initiative is called the Mississippi Health First Collaborative.
The Audit Commission has released a report which calls for NHS organisations and local councils to focus more on the outcomes rather than process of joint working. David Stout, director of the Primary Care Trust Network, responds to the report.
Universal Detection Technology (OTCBB: UNDT), a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, announced that it will showcase the latest developments in bio-weapons detection technology, including the TS-10-5-agent biodetection kit, at Milipol Paris 2009.
Researchers in the US have discovered that the male hormone androgen may trigger the gene fusion that leads to the development of prostate cancer: they found that pieces of chromosome that normally sit far apart, relocate near each other after exposure to androgen, and this sets the scene for the genes to fuse.
Because Medicaid is the nation’s primary payer for mental health services, changes in Medicaid policies-even those policies that are not specifically related to mental health services-can have significant effects on public mental health systems, according to research reported in the November issue of Psychiatric Services, a journal of the American Psychiatric Association.
MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced the presentation of data related to its RNAi oncology programs at the 24th Annual Meeting of the International Society for Biological Therapy of Cancer, taking place October 28-31, 2009 at the Gaylord National Hotel and Convention Center in Washington, D.C. Shaguna Seth, Ph.D.